Follow us on X
Follow us on LinkedIn
Follow us on Youtube
Discover RISE d.o.o


HIPPOCRATES – Promoting Early Identification and Improving Outcomes in Psoriatic Arthritis


Psoriatic Arthritis (PsA) is a clinically heterogenous disease which is associated with a diminished quality of life. Early diagnosis is challenging and prediction of natural history or therapeutic response to treatment is suboptimal. This represents critical, contemporary unmet clinical needs.

By looking into the disease mechanisms of psoriatic arthritis, the 26 partners collaborating in the Horizon 2020 research project HIPPOCRATES aim at improving diagnostic and therapeutic options for patients living with this condition. Through gaining a better understanding of the complex interplay between clinical and environmental factors, genotype and molecular pathways, the team aims to enable earlier diagnosis and a more accurate prediction of disease progression. This will revolutionise treatment and deliver profound patient benefits.

The project budget of EUR 21 million is provided by the Innovative Medicines Initiative (IMI 2), a Joint Undertaking of the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

It is the first Innovative Medicines Initiative (IMI2) project on PsA.

Professor Oliver FitzGerald
University College Dublin
Phone: +35 3872486687
Horizon 2020 & sub-programmes
60 months (July 2021 - June 2026)
Project funding
€ 21,245,992.00
Project partners
Project website
Your contact
Christa Brettar
Senior Project Manager
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Phone: +49 6894 388130
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Phone: +49 30 374415840